SciBase's EIS Technology Selected as Primary Endpoint in NIH Skin Barrier Study

PartnershipEIS TechnologyPositive

AI Analysis

Summary

SciBase's EIS Technology has been selected as the primary endpoint for a new NIH-sponsored skin barrier study. The collaboration represents validation of SciBase's AI-based dermatological device technology.

Clinical Trial Data

Outcome Details

EIS Technology selected as primary endpoint in NIH skin barrier study

Importance:6/10

Sentiment:

0.60

dermatologyAI-based devicesNIH collaborationclinical studyprimary endpoint

Related Companies

$NHPAP

Read the original article

Published by PR Newswire Biotech on October 15, 2026 6:08 AM

Read Original